Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Gross Margin came in at 87.2% in Q4 2025, down 436.0% YoY from 25.95% in Q4 2024, and down 7.93% on a QoQ basis from 94.7% in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 3 years of Gross Margin data on file, last reported at 87.2% in Q4 2025.
- Quarterly Gross Margin fell 436.0% year-over-year to 87.2% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 91.57% (down 173.0% YoY) and the FY2025 annual result came in at 91.57%, down 173.0% from the prior year.
- Gross Margin retreated to 87.2% in Q4 2025, from 94.7% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 97.83% in Q1 2024 to a low of 80.54% in Q3 2024.
- A 3-year average of 92.25% and a median of 93.65% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin slumped 1438 bps — and 2025, when it jumped 1416 bps.
- Tracing FENC's Gross Margin over 3 years: stood at 92.96% in 2023, then slipped by 2 bps to 91.56% in 2024, then fell by 5 bps to 87.2% in 2025.
- The last three Gross Margin figures came in at 87.2% (Q4 2025), 94.7% (Q3 2025), and 89.98% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | 95.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.97% |
| Dec 31, 2025 | 87.20% |
| Sep 30, 2025 | 94.70% |
| Jun 30, 2025 | 89.98% |
| Mar 31, 2025 | 95.74% |
| Dec 31, 2024 | 91.56% |
| Sep 30, 2024 | 80.54% |
| Jun 30, 2024 | 91.63% |
| Mar 31, 2024 | 97.83% |
| Dec 31, 2023 | 92.96% |
| Sep 30, 2023 | 94.92% |
| Jun 30, 2023 | 95.55% |
| Mar 31, 2023 | 94.34% |